A large study found that patients from racial minority groups were less likely to receive certain types of dialysis or to receive kidney transplants.

Dr Amy Pollak talks to Dr William Haley of the Mayo Clinic about how to interpret the results from the SPRINT trial and why practitioners should stay tuned for further results.

'Whatever it takes,' says Dr Jeffrey Berns, we need to get patients with advanced kidney disease into the care of a nephrologist before dialysis is initiated to reduce mortality during the first year.

Dr JoAnn Manson urges clinicians to consider physical activity as a 'vital sign.'

Patient advocates have emerged as sophisticated stakeholders who understand the healthcare system and are knowledgeable about pertinent scientific developments in their disease area.

Eric Topol speaks with author Siddhartha Mukherjee about his latest book, The Laws of Medicine, and how uncertainty, imperfections, priors, outliers, and biases affect these laws.

EMPA-REG may have stolen the show this year, but there were many other fascinating presentations at the annual European diabetes meeting.

Proposals to improve the care of patients with CKD include new payment and patient management models.

Could brown adipose tissue be a pharmacologic target to treat obesity? What is its role in weight loss maintenance? See Eric Ravussin's input on this topic.

Tight blood pressure control may not slow progression of kidney disease, but might it delay mortality?